Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

ALLISON, JAMES P

One or more keywords matched the following items that are connected to ALLISON, JAMES P

Item Type	Name
Concept	Immunotherapy
Concept	Immunotherapy, Adoptive
Academic Article	Combining radiation and immunotherapy: a new systemic therapy for solid tumors?
Academic Article	Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma.
Academic Article	CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases.
Academic Article	Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication.
Academic Article	Defining the critical hurdles in cancer immunotherapy.
Academic Article	Immunological insights from patients undergoing surgery on ipilimumab for metastatic melanoma.
Academic Article	Immune modulation in cancer with antibodies.
Academic Article	Specificity and longevity of antitumor immune responses induced by B7-transfected tumors.
Academic Article	Manipulation of costimulatory signals to enhance antitumor T-cell responses.
Academic Article	Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer.
Academic Article	CTLA-4: new insights into its biological function and use in tumor immunotherapy.
Academic Article	Prostate cancer: advances in immunotherapy.
Academic Article	Checkpoint blockade in cancer immunotherapy.
Academic Article	CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells.
Academic Article	Immunotherapeutic strategies for high-risk bladder cancer.
Academic Article	Targeting immunosupportive cancer therapies: accentuate the positive, eliminate the negative.
Academic Article	Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity.
Academic Article	Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies.
Academic Article	Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido.
Academic Article	Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy.
Academic Article	Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma.
Academic Article	Cancer immunotherapy: breaking the barriers to harvest the crop.
Academic Article	Translation of cancer immunotherapies.
Academic Article	Co-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily.
Academic Article	Breaking down the barriers to cancer immunotherapy.
Academic Article	Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.
Academic Article	Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections.
Academic Article	Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists.
Academic Article	Inhibitors of B7-CD28 costimulation in urologic malignancies.
Academic Article	Anti-CTLA-4 antibody therapy: immune monitoring during clinical development of a novel immunotherapy.
Academic Article	Novel cancer immunotherapy agents with survival benefit: recent successes and next steps.
Academic Article	Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-?B signaling improves the efficacy of immunotherapy in a brain cancer model.
Academic Article	Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4.
Academic Article	Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy.
Academic Article	Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) immunotherapy for the treatment of prostate cancer.
Academic Article	Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
Academic Article	Repertoire enhancement with adoptively transferred female lymphocytes controls the growth of pre-implanted murine prostate cancer.
Academic Article	Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma.
Academic Article	CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit.
Academic Article	Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial.
Academic Article	Enhancement of tumor-reactive cytotoxic CD4+ T cell responses after ipilimumab treatment in four advanced melanoma patients.
Academic Article	Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.
Academic Article	Erratum: anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.
Academic Article	The future of immune checkpoint therapy.
Academic Article	Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential.
Academic Article	Strategies for combining immunotherapy with radiation for anticancer therapy.
Academic Article	Unique potential of 4-1BB agonist antibody to promote durable regression of HPV+ tumors when combined with an E6/E7 peptide vaccine.
Academic Article	Anticancer immunotherapy by CTLA-4 blockade
Academic Article	Deep sequencing of T-cell receptor DNA as a biomarker of clonally expanded TILs in breast cancer after immunotherapy
Academic Article	Anti-CTLA4 in the immunotherapy of malignancies
Academic Article	Strategies for combining immunotherapy with radiation for anticancer therapy
Academic Article	Anticancer immunotherapy by CTLA-4 blockade
Academic Article	Checkpoint blockade and combinatorial immunotherapies
Academic Article	HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes.
Academic Article	Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.
Academic Article	Checkpoints.
Academic Article	De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute.
Academic Article	Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy.
Academic Article	Concurrent OX40 and CD30 Ligand Blockade Abrogates the CD4-Driven Autoimmunity Associated with CTLA4 and PD1 Blockade while Preserving Excellent Anti-CD8 Tumor Immunity.
Academic Article	Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade.
Academic Article	Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade.
Academic Article	Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers.
Academic Article	Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer.
Academic Article	TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion.
Academic Article	Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?
Academic Article	Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers-Response.
Academic Article	Immunologic Correlates of Pathologic Complete Response to Preoperative Immunotherapy in Hepatocellular Carcinoma.
Academic Article	Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated Manner.
Academic Article	Autoimmune antibodies correlate with immune checkpoint therapy-induced toxicities.
Academic Article	Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies.
Academic Article	Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma.
Academic Article	B cells and tertiary lymphoid structures promote immunotherapy response.
Academic Article	Frontiers in cancer immunotherapy-a symposium report.
Academic Article	LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy.
Academic Article	Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck.
Academic Article	Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.
Academic Article	Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck.
Academic Article	Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.
Academic Article	Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration.
Academic Article	Immune checkpoint therapy: Forging ahead.
Academic Article	T cells specific for a-myosin drive immunotherapy-related myocarditis.
Academic Article	Immune checkpoint therapy-current perspectives and future directions.
Academic Article	Cancer Immunology and Immunotherapy Showcased in the AACR Cancer Progress Report 2023.
Academic Article	The future of targeting cytotoxic T-lymphocyte-associated protein-4: Is there a role?

Search Criteria

Immunotherapy